White House Press Secretary Karine Jean-Pierre told reporters on Monday that last week’s decision by a Texas court to ban the nationwide sale and distribution of the abortion pill mifepristone “could open the floodgates for other medications to be targeted and denied to people who need them.” Following that ruling by Judge Matthew Kacsmaryk of the U.S.
District Court for the Northern District of Texas, American Medical Association President Jack Resneck raised similar concerns in a statement warning that “upending longstanding drug regulatory decisions by the U.S.
Food and Drug Administration (FDA)” would position “other drugs at risk of being subject to similar efforts.” “You’re not talking about just mifepristone,” U.S.
Department of Health and Human Services Secretary Xavier Becerra said during an appearance on CNN’s “State of the Union” Sunday. “You’re talking about every kind of drug.